NeueHealth, Inc. (NYSE:NEUE - Get Free Report) insider Jeffery Michael Craig sold 2,486 shares of the business's stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $7.33, for a total value of $18,222.38. Following the completion of the transaction, the insider now directly owns 7,558 shares of the company's stock, valued at approximately $55,400.14. This trade represents a 24.75 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
NeueHealth Stock Performance
NYSE NEUE traded up $0.05 during mid-day trading on Wednesday, reaching $7.45. 38,124 shares of the stock were exchanged, compared to its average volume of 70,685. The company has a market capitalization of $61.72 million, a P/E ratio of -0.15 and a beta of 0.57. The business's 50 day moving average is $5.47 and its 200-day moving average is $5.38. NeueHealth, Inc. has a 1 year low of $3.79 and a 1 year high of $16.59.
Institutional Investors Weigh In On NeueHealth
Hedge funds have recently modified their holdings of the company. Renaissance Technologies LLC purchased a new position in shares of NeueHealth during the 2nd quarter valued at approximately $312,000. Partners Group Holding AG acquired a new position in NeueHealth during the third quarter worth $463,000. Deer Management Co. LLC purchased a new position in NeueHealth during the second quarter valued at $5,436,000. Finally, NEA Management Company LLC acquired a new stake in shares of NeueHealth in the second quarter valued at about $14,834,000. 63.88% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Separately, Royal Bank of Canada decreased their price target on NeueHealth from $8.00 to $7.00 and set a "sector perform" rating for the company in a report on Monday, December 9th.
Read Our Latest Stock Analysis on NeueHealth
About NeueHealth
(
Get Free Report)
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider NeueHealth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NeueHealth wasn't on the list.
While NeueHealth currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
